Precision microbiome medicine and therapeutics: the enabling role of in vitro gut models
FEMS Microbiology Reviews · 02.01.2026 · 50
DOI: 10.1093/femsre/fuag038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEMS Microbiology Reviews, online erschienen am 03.08.2026. Verfasst von Zhan Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France. Hauptthemen laut MEDLINE: Precision Medicine, Gastrointestinal Microbiome, Models, Biological. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The human gut microbiome exhibits profound interindividual variability, challenging the efficacy of generalized interventions and underscoring the need for precision approaches to microbiome-associated diseases. Such strategies require comprehensive, individualized assessment of microbial ecosystems and their functional responses, an objective that remains difficult to achieve in vivo. In vitro gut models offer a promising alternative, maintaining personalized microbial communities in controlled environments and enabling detailed investigation of microbiome dynamics. Complementary microbe–host co-culture systems incorporating human cells further permit mechanistic interrogation of host responses to microbial stimuli. Together, these integrated platforms offer a translational framework for developing tailored therapeutics. In this Perspective, we examine how in vitro gut models can advance microbiome-based personalized medicine, discuss key determinants of therapeutic variability, and outline the relevance, limitations, and future directions of these systems in designing targeted, more effective interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France.
- Gut, Liver & Microbiome Research (GLIMMER) FHU, F-75012 Paris, France.
- Microbiota I-Center (MagIC), Hong Kong SAR, China.
- Department of Medicine and Therapeutics, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- New Cornerstone Science Laboratory, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Gastroenterology, Sorbonne Université, AP-HP, Hôpital Saint Antoine, F-75012 Paris, France.
ORCID-Profile: Nathalie Rolhion
Zitieren
APA
Huang, Z., Ng, S. C., Sokol, H., & Rolhion, N. (2026). Precision microbiome medicine and therapeutics: the enabling role of in vitro gut models. FEMS Microbiology Reviews, 50. https://doi.org/10.1093/femsre/fuag038
Vancouver
Huang Z, Ng SC, Sokol H, Rolhion N. Precision microbiome medicine and therapeutics: the enabling role of in vitro gut models. FEMS Microbiology Reviews. 2026;50. doi:10.1093/femsre/fuag038
BibTeX
@article{Huang2026,
author = {Huang, Zhan and Ng, Siew C and Sokol, Harry and Rolhion, Nathalie},
title = {Precision microbiome medicine and therapeutics: the enabling role of in vitro gut models},
journal = {FEMS Microbiology Reviews},
year = {2026},
volume = {50},
doi = {10.1093/femsre/fuag038}
}
EUVIMED